"Streptococcus pneumoniae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.
| Descriptor ID |
D013296
|
| MeSH Number(s) |
B03.353.750.737.872.550 B03.510.400.800.872.550 B03.510.550.737.872.550
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Streptococcus pneumoniae".
Below are MeSH descriptors whose meaning is more specific than "Streptococcus pneumoniae".
This graph shows the total number of publications written about "Streptococcus pneumoniae" by people in this website by year, and whether "Streptococcus pneumoniae" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 1998 | 2 | 0 | 2 |
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Streptococcus pneumoniae" by people in Profiles.
-
Pore-forming activity of S. pneumoniae pneumolysin disrupts the paracellular localization of the epithelial adherens junction protein E-cadherin. Infect Immun. 2023 09 14; 91(9):e0021323.
-
20-Valent Pneumococcal Conjugate Vaccine in Older People. Sr Care Pharm. 2023 Apr 01; 38(4):148-155.
-
The pneumococcal two-component system SirRH is linked to enhanced intracellular survival of Streptococcus pneumoniae in influenza-infected pulmonary cells. PLoS Pathog. 2020 08; 16(8):e1008761.
-
Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid. Vaccine. 2021 03 12; 39(11):1652-1660.
-
Pneumolysin Induces 12-Lipoxygenase-Dependent Neutrophil Migration during Streptococcus pneumoniae Infection. J Immunol. 2020 01 01; 204(1):101-111.
-
Crosstalk between the serine/threonine kinase StkP and the response regulator ComE controls the stress response and intracellular survival of Streptococcus pneumoniae. PLoS Pathog. 2018 06; 14(6):e1007118.
-
Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection. Clin Vaccine Immunol. 2015 Oct; 22(10):1079-89.
-
Pneumococcal vaccination-promoting health. J Am Osteopath Assoc. 2015 Jun; 115(6 Suppl):S4-5.
-
Stress-triggered signaling affecting survival or suicide of Streptococcus pneumoniae. Int J Med Microbiol. 2015 Jan; 305(1):157-69.
-
The impact of pneumolysin on the macrophage response to Streptococcus pneumoniae is strain-dependent. PLoS One. 2014; 9(8):e103625.